Patient Derived Xenograft (PDX) Model Market, By Tumor Type, By Model, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

List of Tables

REPORT HIGHLIGHT

Patient Derived Xenograft (PDX) Model Market size was valued at USD 290.6 Million in 2022, expanding at a CAGR of 13.2% from 2023 to 2030.

Patient-derived xenografts (PDX) are cancer models in which a patient's tumor tissue or cells are implanted into immunocompromised or humanized mice. This procedure involves xenotransplantation. To maintain the development of cancer after it has been removed from a patient, PDX models are employed. This allows for the monitoring of tumor development in the lab, including how it responds to various therapy choices. A PDX model from a given patient can be evaluated against a variety of medicines in a 'personalized oncology' approach, or cohorts of PDX models can be used to assess the therapeutic effectiveness of a drug against distinct forms of cancer.

Patient Derived Xenograft (PDX) Model Market - Market Dynamics:

The growing prevalence of cancer across the globe drives the market growth

The growing prevalence of cancer across the globe is expected to drive market growth during the forecast period. For instance, according to the report published by National Cancer Institutes, there would be 18.1 million cancer survivors in the US as of January 2022. This is equivalent to around 5.4% of the total population. In the United States, 623,405 persons have metastatic breast, prostate, lung, colorectal, bladder, or melanoma, and by the year 2025, that number is projected to rise to 693,452. Moreover, as per the data by Cancer Research UK, it is anticipated that there will be 28 million new cancer cases globally each year by 2040 if incidence remains steady and population growth and ageing continue at current rates. This is a 54.9% increase over 2020, and it is predicted to be larger in males (60.6% increase) than in women (48.8% increase). Thus, the aforementioned facts drive the market growth during the forecast period.

Patient Derived Xenograft (PDX) Model Market - Key Insights:

As per the analysis shared by our research analyst, the global Patient Derived Xenograft (PDX) Model market is estimated to grow annually at a CAGR of around 13.2% over the forecast period (2023-2030)

Patient Derived Xenograft (PDX) Model industry is projected to grow at a significant rate owing to the growing prevalence of cancer.

Based on the tumor type, the breast cancer segment is expected to dominate the market over the forecast period.

Based on region, North America is expected to dominate the market over the forecast period.

Patient Derived Xenograft (PDX) Model Market- Segmentation Analysis:

The Global Patient Derived Xenograft (PDX) Model Market is segmented based on tumor type, model, end user and Region.

Based on the tumor type, the global Patient Derived Xenograft (PDX) Model market is segmented into prostate cancer, pancreatic cancer, lung cancer, breast cancer and others. The breast cancer segment is expected to dominate the market during the forecast period. Breast cancer still ranks as the leading cause of death for women worldwide, despite major improvements in detection and treatment methods over time. With current medicines, it is challenging to destroy tumors since they are made up of populations that are extremely varied, including those of breast cancer. Due to the inter-tumor heterogeneity of breast cancer, it is also difficult to accurately predict therapeutic efficacy using commonly used cancer models, such as cell lines created in vitro and in vivo. As a result, PDX models have been created to more realistically depict the variability of the origins of human malignancies. These models are expected to improve breast cancer therapy modalities. Thereby, driving the segment growth over the forecast period.

Patient Derived Xenograft (PDX) Model Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period due to the increasing prevalence of cancer. Moreover, the increasing R&D investments are also an important factor that propels the industry expansion. Furthermore, the presence of key players in the region is expected to propel the market growth. For instance, in April 2023, at the 2023 American Association for Cancer Research (AACR) Annual Meeting, Vincerx Pharma, Inc., a biopharmaceutical company aiming to address the unmet medical needs of cancer patients through paradigm-shifting therapeutics, presented a poster of preclinical data of VIP236 monotherapy treatment in PDX and metastatic PDX mouse models across various tumor types. Thus, this kind of initiative is expected to drive market growth in the region.

Patient Derived Xenograft (PDX) Model Market- Competitive Landscape:

The key players operating in the market are: WuXi AppTec, XenTech, Crown Bioscience, Altogen Labs, Envigo, Charles River Laboratories, Oncodesign, Hera Biolabs, The Jackson Laboratory and Abnova Corp.

Recent Developments:

In July 2022, GemPharmatech (GemPharmatech Co., Ltd.) announced that it has entered into a strategic license agreement with Charles River Laboratories, Inc. for the exclusive distribution of its next-generation NOD CRISPR Prkdc Il2r gamma (NCG) mouse lines in North America. The goal of this agreement is to speed up the development of novel therapeutics for a variety of unmet medical needs, particularly in immuno-oncology. To produce models that will be sold starting in 2023, Charles River will create foundation colonies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET KEY PLAYERS

WuXi AppTec
XenTech
Crown Bioscience
Altogen Labs
Envigo
Charles River Laboratories
Oncodesign
Hera Biolabs
The Jackson Laboratory
Abnova Corp.

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY TUMOR TYPE

Prostate Cancer
Pancreatic Cancer
Lung Cancer
Breast Cancer
Others

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY MODEL

Mice
Rats

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY END USER

Pharmaceutical And Biopharmaceutical Companies
Academic & Research Institutes
CROs & CDMOs

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY REGION

North America

The U.S.
Canada

Europe

Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe

Asia Pacific

India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC

Latin America

Brazil
Mexico
Argentina
Colombia
Rest of LATAM

The Middle East and Africa

Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV1643

1. Patient Derived Xenograft (PDX) Model Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Patient Derived Xenograft (PDX) Model Market Snippet by Tumor Type
- 2.1.2. Patient Derived Xenograft (PDX) Model Market Snippet by Model
- 2.1.3. Patient Derived Xenograft (PDX) Model Market Snippet by End User
- 2.1.4. Patient Derived Xenograft (PDX) Model Market Snippet by Country
- 2.1.5. Patient Derived Xenograft (PDX) Model Market Snippet by Region
2.2. Competitive Insights

3. Patient Derived Xenograft (PDX) Model Key Market Trends

3.1. Patient Derived Xenograft (PDX) Model Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Patient Derived Xenograft (PDX) Model Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Patient Derived Xenograft (PDX) Model Market Opportunities
3.4. Patient Derived Xenograft (PDX) Model Market Future Trends

4. Patient Derived Xenograft (PDX) Model Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Patient Derived Xenograft (PDX) Model Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Patient Derived Xenograft (PDX) Model Market Landscape

6.1. Patient Derived Xenograft (PDX) Model Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Patient Derived Xenograft (PDX) Model Market - By Tumor Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Tumor Type, 2022 & 2030 (%)
- 7.1.2. Prostate Cancer
- 7.1.3. Pancreatic Cancer
- 7.1.4. Lung Cancer
- 7.1.5. Breast Cancer
- 7.1.6. Others

8. Patient Derived Xenograft (PDX) Model Market - By Model

8.1. Overview
- 8.1.1. Segment Share Analysis, By Model, 2022 & 2030 (%)
- 8.1.2. Mice
- 8.1.3. Rats

9. Patient Derived Xenograft (PDX) Model Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
- 9.1.2. Pharmaceutical And Biopharmaceutical Companies
- 9.1.3. Academic & Research Institutes
- 9.1.4. CROs & CDMOs

10. Patient Derived Xenograft (PDX) Model Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Patient Derived Xenograft (PDX) Model Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Tumor Type, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Model, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Patient Derived Xenograft (PDX) Model Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. WuXi AppTec
- 11.2.2. XenTech
- 11.2.3. Crown Bioscience
- 11.2.4. Altogen Labs
- 11.2.5. Envigo
- 11.2.6. Charles River Laboratories
- 11.2.7. Oncodesign
- 11.2.8. Hera Biolabs
- 11.2.9. The Jackson Laboratory
- 11.2.10. Abnova Corp.

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

Product Code: ANV1643

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Patient Derived Xenograft (PDX) Model Market: Tumor Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Tumor Type
TABLE Global Patient Derived Xenograft (PDX) Model Market, by Tumor Type 2018-2030 (USD Million)
TABLE Patient Derived Xenograft (PDX) Model Market: Model Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Model
TABLE Global Patient Derived Xenograft (PDX) Model Market, by Model 2018-2030 (USD Million)
TABLE Patient Derived Xenograft (PDX) Model Market: End User Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by End User
TABLE Global Patient Derived Xenograft (PDX) Model Market, by End User 2018-2030 (USD Million)
TABLE Patient Derived Xenograft (PDX) Model Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Patient Derived Xenograft (PDX) Model Market, by Region 2018-2030 (USD Million)
TABLE North America Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
TABLE North America Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
TABLE North America Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
TABLE North America Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)
TABLE Europe Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
TABLE Europe Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
TABLE Europe Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
TABLE Europe Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)
TABLE Asia Pacific Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
TABLE Asia Pacific Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
TABLE Asia Pacific Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)
TABLE Latin America Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
TABLE Latin America Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
TABLE Latin America Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)
TABLE Middle East and Africa Patient Derived Xenograft (PDX) Model Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Patient Derived Xenograft (PDX) Model Market, by Tumor Type, 2018-2030 (USD Million)
TABLE Middle East and Africa Patient Derived Xenograft (PDX) Model Market, by Model, 2018-2030 (USD Million)
TABLE Middle East and Africa Patient Derived Xenograft (PDX) Model Market, by End User, 2018-2030 (USD Million)

Patient Derived Xenograft (PDX) Model Market, By Tumor Type, By Model, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

Description

Table of Contents

List of Tables

REPORT HIGHLIGHT

Patient Derived Xenograft (PDX) Model Market - Market Dynamics:

Patient Derived Xenograft (PDX) Model Market - Key Insights:

Patient Derived Xenograft (PDX) Model Market- Segmentation Analysis:

Patient Derived Xenograft (PDX) Model Market- Geographical Insights

Patient Derived Xenograft (PDX) Model Market- Competitive Landscape:

Recent Developments:

SCOPE OF THE REPORT

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET KEY PLAYERS

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY TUMOR TYPE

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY MODEL

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY END USER

GLOBAL PATIENT DERIVED XENOGRAFT (PDX) MODEL MARKET, BY REGION

Table of Contents

1. Patient Derived Xenograft (PDX) Model Market Overview

2. Executive Summary

3. Patient Derived Xenograft (PDX) Model Key Market Trends

4. Patient Derived Xenograft (PDX) Model Industry Study

5. Patient Derived Xenograft (PDX) Model Market: COVID-19 Impact Analysis

6. Patient Derived Xenograft (PDX) Model Market Landscape

7. Patient Derived Xenograft (PDX) Model Market - By Tumor Type

8. Patient Derived Xenograft (PDX) Model Market - By Model

9. Patient Derived Xenograft (PDX) Model Market - By End User

10. Patient Derived Xenograft (PDX) Model Market- By Geography

11. Key Vendor Analysis- Patient Derived Xenograft (PDX) Model Industry

12. 360 Degree Analyst View

13. Appendix

List of Tables